Global Needle Free Injection Systems Market, By Type (Liquid-Based Needle-Free Injectors, Projectile/Depot-Based Needle-Free Injectors, Powder-Based Needle Free Injectors), Product (Fillable Needle-Free Injectors, Prefilled Needle-Free Injectors), Technology (Jet-Based Needle-Free Injectors, Spring Global Needle Free Injectors, Laser-Powered Needle-Free Injectors, Vibration-Based Needle-Free Injectors), Usability (Disposable Needle-Free Injectors, Reusable Needle-Free Injectors), Site of Delivery (Subcutaneous Injectors, Intramuscular Injectors, Intradermal Injectors), Application (Vaccine Delivery, Insulin Delivery, Oncology, Pain Management, Other), End User (Hospitals and Clinics, Home Care Settings, Research Laboratories, Pharmaceutical and Biotechnological Companies, Other), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2029.
Market Analysis and Insights of Needle Free Injection Systems Market
Data Bridge Market Research analyses that the needle free injection systems market growing at a CAGR of 15.46% in the forecast period of 2022-2029. The widespread presence of chronic diseases and increasing rate of communicable diseases is driving the growth of the needle free injection systems market.
Traditionally, drugs are administered to humans via needles and injections. However, a new concept, needle free injection technology (NFIT), has recently been introduced into the market, which includes a wide range of drug delivery systems. Drugs are delivered through the skin using forces such as shock waves, gas pressure, or electrophoresis. This technique or force propels the drug through the skin, eliminating the need for a hypodermic needle.
The growing number of diabetes cases around the world has created a demand for self-injection systems, which are efficiently met by needle free injection systems; thus, the growing demand for self-medication is fueling the market's growth. Furthermore, the rising prevalence of chronic diseases, as well as an increase in the use of injectable drugs for treatment, are driving demand for the needle free injection systems market. Injectable drug delivery systems have several advantages over oral drug delivery systems, including faster onset of action and maximum bioavailability, making them suitable for use in emergency situations to provide faster relief. Furthermore, it does not cause pain during administration, and needle free injection systems confine the drugs more evenly in the dermis throughout the skin.
Also, the needle free injection systems help to eliminate the risk of infection. As a result of the advantages over conventional needle systems, the market for needle free injection systems is expanding rapidly.
However, huge development costs, as well as stringent device regulations, are likely to impede the growth of the needle free injection systems market during the forecast period.
This needle free injection systems market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on needle free injection systems market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Needle Free Injection Systems Market Scope and Market Size
Needle free injection systems market is segmented on the basis of type, product, technology, usability, site of delivery, application and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- Based on type, the needle free injection systems market is segmented into liquid-based needle-free injectors, projectile/depot-based needle-free injectors, and powder-based needle free injectors.
- Needle free injection systems market has also been segmented based on the product into fillable needle-free injectors and prefilled needle-free injectors.
- On the basis of technology, the needle free injection systems market is segmented into jet-based needle-free injectors, spring-based needle-free injectors, laser-powered needle-free injectors and vibration-based needle-free injectors.
- On the basis of usability, the needle free injection systems market is segmented into disposable needle-free injectors and reusable needle-free injectors.
- On the basis of site of delivery, the needle free injection systems market is segmented into subcutaneous injectors, intramuscular injectors and intradermal injectors.
- Based on application, the needle free injection systems market is segmented into vaccine delivery, insulin delivery, oncology, and pain management and other.
- On the basis of end user, the needle free injection systems market is segmented into hospitals and clinics, home care settings, research laboratories, pharmaceutical and biotechnological companies and other.
Needle Free Injection Systems Market Country Level Analysis
Needle free injection systems market is segmented on the basis of type, product, technology, usability, site of delivery, application and end user.
The countries covered in the needle free injection systems market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the needle free injection systems market due to increased investment in research and development, whereas Europe is expected to grow at the fastest rate during the forecast period of 2022 to 2029 due to rising demand for biologics, increasing prevalence of chronic diseases, technological advancements, mergers and acquisitions by major market players, favourable reimbursement policies, increasing healthcare expenditure, and regulatory requirements.
The country section of the needle free injection systems market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The needle free injection systems market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for needle free injection systems market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the needle free injection systems market. The data is available for historic period 2010 to 2020.
Competitive Landscape and Needle Free Injection Systems Market Share Analysis
The needle free injection systems market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to needle free injection systems market.
Ome of the major players operating in the needle free injection systems market are Antares Pharma, Endo Pharmaceuticals Inc., Bioject Medical Technologies Inc., Medical International Technology, Inc., INJEX Pharma AG, National Medical Products Co. Ltd., Valeritas, Inc., InsuJet, PenJet, Crossject, Portal Instruments, Amico Group, BD, InsuJet, Glide Pharmaceutical Technologies Limited, Inovio Pharmaceuticals, Inc., MedImmune, Mystic Pharmaceuticals, OptiNose US, Zogenix, Inc and D'Antonio Consultants International, Inc. among others.